AI in India’s Healthcare: What Are the Latest Updates?

Welcome, reader!

Today, AI in healthcare has gone far beyond sitting quietly in strategy decks and research tabs.

In India, AI now shows up across public health programmes, diagnostic workflows, telemedicine systems, disease surveillance, medical device regulation, and even national policy conversations.

But here’s a question for you.
Are we moving from “AI can help healthcare” to “AI is now being tested inside real healthcare systems”?

That is the shift we are exploring in this edition.

—

Fact Check

DYK? India has recently launched the Strategy for AI in Healthcare in India (SAHI) and the Benchmarking Open Data Platform for Health AI (BODH) to support safer, evidence-based, and scalable AI deployment in healthcare. BODH, developed with IIT Kanpur, is designed to help test and validate AI solutions before large-scale use (Source).
—

A Quick Recap

In our last edition, we looked at Awareness to Action: Designing Content that Supports Better Decision Making Among Patients. Our newsletter explored how better science communication can help audiences move from awareness to understanding.

---

What’s Inside?

In this edition, we look at:

- Why AI in Indian healthcare is moving from promise to practice?
- What recent research and policy updates are saying?
- How are Indian companies testing AI in real-world diagnostic settings?
- Why trust, validation, and explainability matter as much as innovation?
- What is SciRio doing to reshape science communication through AI?

---

Take a Quick Poll

What excites you most about AI in Indian healthcare?

A. Faster diagnosis
B. Better access in smaller cities and rural areas
C. Personalised care and predictive health
D. Reduced pressure on doctors and specialists
E. I’m still cautious about clinical AI

---

Featured Insight: What Does the Trend Say?

The research conversation around AI in healthcare has become more grounded. A few years ago, most discussions focused on what AI could do.

Today, the focus is shifting towards what AI must prove before it can be trusted in healthcare: safety, accuracy, equity, clinical validation, data privacy, workflow fit, and human oversight.

In India, this matters deeply. We are a country with high patient volumes, uneven specialist access, fragmented health data, and wide variation between urban tertiary hospitals and smaller care settings. In that context, AI is being explored not as a replacement for clinicians, but as a tool that can support screening, triage, early detection, workflow automation, and public health decision-making.

Recent literature on AI in Indian healthcare highlights several promising use cases: early disease detection, diagnostic support, population-level risk prediction, outbreak forecasting, and personalised care. But it also points to familiar risks: biased datasets, weak infrastructure, privacy concerns, and the need for stronger ethical and regulatory frameworks.

This is where India’s AI-healthcare story becomes especially interesting.

The Ministry of Health has stated that AI-enabled tools have been used across areas such as TB management, diabetic retinopathy screening, disease surveillance, telemedicine, and malnutrition monitoring.

Government updates have also reported AI-enabled deployments in public health programmes, including adverse outcome prediction in TB care and outbreak alerts through surveillance systems.

At the same time, India is building the governance layer around AI. The ICMR’s ethical guidelines for AI in biomedical research and healthcare emphasise responsible development, ethics review, governance, informed consent, and stakeholder accountability. Importantly, the guidelines describe themselves as a “living document”, recognising that AI ethics will continue to evolve.

So, the real update is not simply that AI is entering Indian healthcare. The update is that AI is entering healthcare through three parallel doors:

- Clinical utility — Can it improve diagnosis, screening, triage, or workflow?
- System readiness — Can it work within real hospitals, public programmes, and digital health infrastructure?
- Trust and governance — Can it be validated, regulated, explained, and responsibly deployed?

For healthcare AI, the science is only one part of the story. The communication around that science will decide how patients, clinicians, regulators, and institutions understand its value.

---

Innovation Showcase:

One Indian company that reflects this shift is Qure.ai, a Mumbai-based healthcare AI company working in radiology and public health diagnostics.

In February 2026, Qure.ai released its India Impact Report, which brought together real-world evidence from public health programmes, state-level deployments, and clinical studies. The report focuses on how AI can be embedded into existing healthcare workflows to support faster diagnosis, reduce delays, and improve access to timely care.

What makes this case important is not just the technology. It is the implementation model.

This is a useful case study because it shows what healthcare AI needs to become useful in India:

- AI must fit into existing workflows.
- AI must reduce burden, not create new complexity.
- AI must work in public health settings, not just premium hospitals.
- AI must generate evidence in real-world conditions.
- AI must communicate its clinical value clearly to doctors, administrators, policymakers, and patients.

That last point is often underestimated.

AI in healthcare is not just a product story. It is a trust story.

For adoption to happen, people need to understand what the tool does, what it does not do, how it was validated, where it fits in the care pathway, and why a clinician should trust its output.

---

Behind the Scenes:

At SciRio, we have been thinking carefully about what AI means for science, healthcare, and communication.

From a practical question: How do we help science-led organisations use AI without losing scientific accuracy, regulatory sensitivity, or human trust?

Across our work with healthcare, biotech, diagnostics, genomics, and deep-tech clients, we are seeing a clear pattern. AI can help teams write, summarise, analyse, brainstorm, and structure information faster. But in science and healthcare, speed alone is not enough.

The real value comes when AI is paired with:

- Scientific reviews
- Expert opinions
- Source-backed writing
- Ethical communication
- Audience-specific storytelling
- Careful distinction between evidence, interpretation, and claim

This is especially important in healthcare, where one poorly phrased claim can create confusion, overpromise, or risk.

So, our internal AI initiatives are focused on using AI as a thinking and drafting partner, not as a substitute for domain expertise. We are exploring how AI can support literature synthesis, scientific content planning, explainer development, workshop design, medical communication workflows, and responsible content review.

SciRio's Goal with AI is Simple:
Use AI to make science communication sharper, not shallower.

—

Blog Spotlight

When Hospitals Become Businesses, Communication Optimises for Metrics — Not Meaning.

As AI brings more automation and optimisation into healthcare, this SciRio article asks an important question: what happens when communication starts serving metrics instead of meaning?

The blog explores how healthcare language can shift from care and reassurance to conversion, journeys, performance, and why patient-first communication must remain central.

—

Final Word

AI in Indian healthcare is entering a more serious phase.

The conversation is no longer only about futuristic possibilities. It is about implementation, validation, regulation, and trust.

That is good news.

Because healthcare does not need AI, that only sounds impressive. It needs AI that is clinically useful, ethically deployed, responsibly communicated, and understood by the people who will use it. 

At SciRio, we believe AI is a critical tool to build and deploy precise science communication in India. See you in the next edition.

Missed the last edition?

Read it here.